
Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY
Q1 Results FY26
Updated: 11 Aug 2025 • 1:21 pm
Posted by:

Concord Biotech Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹203.99 | ₹215.80 |
| Profit Before Tax (PBT) | ₹75.08 | ₹91.59 |
| Profit After Tax (PAT) | ₹44.06 | ₹59.59 |
(Figures in crores)
Concord Biotech Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹203.99 | ₹215.80 |
| Profit Before Tax (PBT) | ₹75.08 | ₹91.59 |
| Profit After Tax (PAT) | ₹42.57 | ₹58.24 |
(Figures in crores)
Concord Biotech Q1 Results FY26 Highlights (Q1 FY26 vs FY25)
- Concord Biotech clocked Q1 FY26 consolidated revenue of ₹203.99 crores vs ₹215.80 crores.
- On the profit front, Concord Biotech earned a consolidated PAT of ₹44.06 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹59.59 crore.
- Consolidated PAT fell for the first quarter of FY26, was 26.07% YoY, and revenue fell 5.47% YoY.
- As per the standalone figures, the quarterly PAT of Concord Biotech has decreased by 26.91%, and revenue has decreased by 5.47% YoY.
Concord Biotech Share Price Performance
On the opening bell of 11th August 2025, the shares of Concord Biotech opened at ₹1,485.80 per share. However, the initial gains are sustained as of now, and Concord Biotech shares are trading at ₹1,571.80 per share, higher than their opening price.
Considering the long-term performance, Concord Biotech shares have yielded close to 4.00% returns in the past 1 year, and 5-year returns stand at 66.55%. Over the maximum timeframe, the Concord Biotech share provided 66.55% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Concord Biotech shares after thorough research.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Also Read : Aurobindo Pharma Q1 Results FY26: Q1 PAT Narrows 10.28% to ₹824.75 Crore; Revenue Surged 3.98% YoY
Recent Articles
Mahendra Realtors IPO GMP & Review: Apply or Avoid?
Regaal Resources IPO GMP & Review: Apply or Avoid?
Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?
Titan Q1 Results FY26: Q1 PAT Rises 52.59% to ₹1,091.00 Crore; Revenue Up 24.55% YoY
Kalyan Jewellers India Q1 Results FY26: Q1 PAT Rises 48.56% to ₹264.08 Crore; Revenue Up 31.49% YoY
Solar Industries Q1 Results FY26: Q1 PAT Rises 18.24% to ₹132.13 Crore; Revenue Up 27.88% YoY
NBCC India Q1 Results FY26: Q1 PAT Rises 26.29% to ₹132.13 Crore; Revenue Up 11.61% YoY
Recent Articles

Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
18 November 2026

V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
18 November 2026

Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
18 November 2026

Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
18 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
Mahanadi Coalfields IPO Opens 19 November: Rs 129 to Rs 136 Price Band, Rs 8,981 Crore Offer for Sale and a Coal India Unit Valued at About 8.4 Times Earnings

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





